Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating cisplatin and gemcitabine with trastuzumab in stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN) [Phase 2]
Phase 2 clinical trial update for a PARP inhibitor in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC [Phase 2]
Phase 2 trial exploring a combination of EGFR-TKIs with anlotinib as first-line therapy for advanced EGFR mutation-positive non-small cell l…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update for LY573636-Sodium in patients with metastatic non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Sunitinib Non Small Cell Lung Cancer Patients Over 70 [Phase 2]
Phase 2 trial update of sunitinib in non-small cell lung cancer patients over 70 completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of VAL401 in locally advanced or metastatic non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC [Phase 2]
Phase 2 trial comparing anlotinib to docetaxel as second-line therapy in EGFR wild-type advanced non-small cell lung cancer; status of the t…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of ABT-751 with carboplatin in advanced lung cancer has been terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma [Phase 2]
Phase 2 trial evaluating minimum dose computed tomography for follow-up in patients with resected non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer [NA]
A completed clinical trial update on stereotactic body radiation therapy for stage II/III non-small cell lung cancer, with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities [Phase 2]
Phase 2 clinical trial update for PDR001 in patients with non-small cell lung cancer harboring KRAS/NRAS mutations or no actionable genetic …
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation [Phase 2]
Phase 2 clinical trial update for capmatinib in non-small cell lung cancer with MET exon 14 skipping mutation.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating NGR-hTNF in combination with standard chemotherapy for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-24Clinical Trial Update: Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly [Phase 4]
Phase 4 trial update on Abraxane plus Carboplatin for advanced non-small cell lung cancer in the elderly; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA [Phase 2]
Phase II study of AZD9291 in advanced non-small cell lung cancer with EGFR and T790M mutations detected in plasma Ct-DNA is in phase 2 with …
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy [Phase 2]
Phase 2 trial investigating correlation between Erlotinib-induced rash and efficacy in EGFR-mutated advanced non-small cell lung cancer pati…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients [Phase 2]
Phase 2 trial assessing concurrent chemoradiotherapy with anlotinib for unresectable stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients [Phase 2]
A Phase 2 clinical trial evaluates docetaxel with or without XH1 in non-small cell lung cancer, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations [Phase 2]
Phase 2 trial evaluating Erlotinib as first-line therapy in EGFR-mutated non-squamous non-small cell lung cancer has completed with results …
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer [Phase 2, Phase 3]
A clinical trial update comparing erlotinib to gemcitabine/cisplatin as (neo)adjuvant treatment for non-small cell lung cancer across Phase …
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology. [Phase 1]
Phase I/II study evaluating continuous oral BIBF 1120 (nintedanib) added to standard gemcitabine/cisplatin therapy in first-line non-small c…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Long-term Observation PMS for Afatinib
Long-term observation study update for afatinib in non-small cell lung cancer has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating Endostar with gemcitabine and cisplatin for non-small cell lung cancer is reported as a status update wi…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma [Phase 3]
Phase 3 clinical trial evaluating gefitinib as adjuvant therapy after chemotherapy for lung adenocarcinoma (NSCLC) with EGFR mutation.